Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-29 · accession 0001437749-21-027506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-30 | 2021-11-29 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $2.55 | +2,500 | 25.0K | +11% | +$6,375 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-29 | P | A | 2,500 | $2.55 | 24,958 | D | — | — | (F1) Holdings do not include options to purchase 42,189 shares, and do not include 4,125 restricted shares. |